|Number of samples:||24|
|Release date:||Jun 8 2017|
|Last update date:||Nov 28 2018|
|Diseases:||Prostatic Neoplasms, Tumor Lysis Syndrome, Tooth Loss|
|Dataset link||Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [VCaP RNA-Seq]|
VCaP cells were infected with lentivirus 1: Tet-inducible shERG, followed by lentivirus 2: shERF or shNT, and selected with two different antibiotics. Subsequently, cells were treated with 100ng/mL doxycycline vs vehicle, 1nM DHT x 16h vs vehicle, or both vs vehicle. For each condition, 3 sets of equal numbers of cells were plated and then processed independently.